John Patrick Shannon Jr. - 01 Aug 2026 Form 4 Insider Report for Xeris Biopharma Holdings, Inc. (XERS)

Reporting relationship: Chief Executive Officer and Chairman of the Board, Director
Issuer ticker: XERS
Reported as of: 01 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Aug 2026, 16:23:22 UTC
Prior SEC filing: 02 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Beth Hecht, Attorney-in-Fact

Key filing fact

John Patrick Shannon Jr. filed Form 4 for Xeris Biopharma Holdings, Inc. (XERS) on 21 Aug 2026.

Key facts

This page summarizes John Patrick Shannon Jr.'s Form 4 filing for Xeris Biopharma Holdings, Inc. (XERS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Aug 2026, 16:23.

Change

Previous filing in this sequence was filed on 02 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001553595 Primary reporting owner

Shannon John Patrick Jr

Relationship: Chief Executive Officer and Chairman of the Board, Director
Address: C/O XERIS BIOPHARMA HOLDINGS, INC., 1375 WEST FULTON STREET, SUITE 1300, CHICAGO
Signature: /s/ Beth Hecht, Attorney-in-Fact
Signature date: 21 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XERS transaction

Common Stock

Tax liability

Transaction value
Shares: -36,645
Change %: -1.2%
Price: $8.08^*
Shares after: 2,898,933
Date: 01 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2026.

SEC remarks

Chief Executive Officer and Chairman of the Board